Trial Profile
52 week multicenter, randomized, double-blind placebo-controlled trial evaluating the efficacy and safety of SNMC in patients with chronic hepatitis C
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 28 Aug 2012
Price :
$35
*
At a glance
- Drugs Glycyrrhizin (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 14 May 2011 New trial record